Skip to Content
Søg Menu

Combination Therapy with Enzalutamide and Radium-223 in mCRPC: Insights from the REASSURE Study

Interview: At ESMO 2025, Professor Igle Jan de Jong shared new insights from the REASSURE study, highlighting that the combination of enzalutamide and radium-223 is safe, well-tolerated, and promising for patients with mCRPC.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

LBA20: Sacituzumab govitecan significantly prolongs PFS versus chemotherapy in advanced triple-negative breast cancer

/ Jan Andreasen
ESMO25NBCNBrystcancer

ESMO 2025: De-Escalated Chemotherapy Prior to Maintenance Avelumab Is Effective in Advanced Urothelial Cancer

/ Enrique Grande
ESMO25Blærecancer Play the Video 04:57
Jakob Lauritsen

ESMO 2025: De-eskaleret kemoterapi før vedligeholdelses-behandling med avelumab

/ Jakob Lauritsen
ESMO25Blærecancer Play the Video 01:15
John Crown

ESMO 2025: Ribociclib + NSAI Reduced the Risk of Invasive and Distant Recurrence of HR+/HER2−Early Breast Cancer

/ John Crown
ESMO25NBCNBrystcancer Play the Video 03:24
Charles Geyer

ESMO 2025: Paradigm Shift in Breast Cancer Treatment

/ Charles E Geyer Jr.
ESMO25NBCNBrystcancer Play the Video 05:53
Jakob Lauritsen

ESMO 2025: Interesting New Data on the Treatment of Bladder Cancer

/ Jakob Lauritsen
ESMO25Blærecancer Play the Video 03:47
Hildur Helgadottir

ESMO 2025: Superior Outcomes With Reduced NIVO+IPI Dose in Advanced Melanoma

/ Hildur Helgadottir
ESMO25Melanom Play the Video 05:27
Katarina Puco

ESMO 2025: Precision Medicine Trial Shows Promise in Rare Cancers

/ Katarina Puco
ESMO25 Play the Video 01:56

ESMO 2025: Advancements to Improve Patient Outcomes and Quality of Life in Immunotherapy

/ Christina Ruhlmann
ESMO25 Play the Video 4:45

Brænder du for at skrive?

Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk

Send mail til redaktionen
Back to top